ChemAbout

ChemAbout is a B2B platform where chemical buyers and suppliers discover each other.

Post a purchase requestList your products (for suppliers)
© 2026 ChemAbout
Compound Index|Demand Board|Insights|Exhibitions|Compliance|Help Center|Privacy Policy|Terms of Service|[email protected]
Home/Compounds/Research Reagent/Boc-Val-Cit-PABA
C23H37N5O6
479.6 g/mol
Research Reagent

Boc-Val-Cit-PABA

CAS870487-09-5
Category
Research Reagent
Compound Class
Peptide
Primary Use
Research Compound

Boc-Val-Cit-PABA is a research compound used as a linker building block in antibody-drug conjugate (ADC) development. It contains a tert-butyloxycarbonyl (Boc)-protected valine-citrulline dipeptide linked to a para-aminobenzyl alcohol (PABA) moiety, providing a stable yet cleavable structure for controlled drug release.

research compound for ADC linker constructionbuilding block in ADC manufacturinglaboratory reagent for conjugation studies

Content scope: Information here supports chemical identification and industrial supply, research, and manufacturing contexts. It is not a therapeutic claim, medical advice, or drug-use instructions.

Sourcing Boc-Val-Cit-PABA?

Post a free purchase request — no account needed. It reaches suppliers of this product, and replies go straight to your inbox.

Post a Purchase Request→Supplier? List your product for this CAS→

Related Compounds

SimilarStructure SimilarSimilarity 0.74

ALLOC-VAL-CIT-PAB-OH

CAS1608127-09-8

pharmaceutical intermediate

ReferenceSame Category

5-Chloro-3-iodo-2-methylaniline

CAS870606-29-4

research compound

ReferenceSame Category

4-(1-Naphthyl)phenylboronic acid

CAS870774-25-7

research compound

ReferenceSame Category

2-Amino-N,3-dimethylbenzamide

CAS870997-57-2

research compound

ReferenceSame Category

3-Amino-5-bromopyridine-2-carboxylic acid

CAS870997-85-6

research compound

Related Reading

Therapeutic Peptides in 2026: This Year's Breakthroughs

2026 has been a concentrated year for peptide therapeutics. Efficacy reached a new high in late-stage trials, the obesity field moved beyond the incretins to amylin, the oral route reached weight management, and peptide-guided radioligand therapy kept advancing — each point tied to a specific 2025–2026 result.

Read more
Identifiers
IUPAC Name

tert-butyl N-[(2S)-1-[[(2S)-5-(carbamoylamino)-1-[4-(hydroxymethyl)anilino]-1-oxopentan-2-yl]amino]-3-methyl-1-oxobutan-2-yl]carbamate

InChIKey

VYCVAPFXSOAOCL-ROUUACIJSA-N

SMILES

CC(C)[C@@H](C(=O)N[C@@H](CCCNC(=O)N)C(=O)NC1=CC=C(C=C1)CO)NC(=O)OC(C)(C)C

Synonyms (8)
  • Boc-Val-Cit-PAB
  • Boc-Val-Cit-PAB-OH
  • Boc-Val-Cit-PABA

Sourcing Boc-Val-Cit-PABA?

Post a free purchase request — no account needed. It reaches suppliers of this product, and replies go straight to your inbox.

Post a Purchase Request→Supplier? List your product for this CAS→